Title: A Double-Pronged Sword: XJB-5-131 Is a Suppressor of Somatic Instability and Toxicity in Huntington’s Disease

Journal Article · · Journal of Huntington's Disease
DOI: https://doi.org/10.3233/jhd-210510 · OSTI ID:1892178
 [1];  [2];  [2]
  1. Univ. of Pittsburgh, PA (United States)
  2. Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States). Molecular Biophysics and Integrated Bioimaging

Due to large increases in the elderly populations across the world, age-related diseases are expected to expand dramatically in the coming years. Among these, neurodegenerative diseases will be among the most devastating in terms of their emotional and economic impact on patients, their families, and associated subsidized health costs. There is no currently available cure or rescue for dying brain cells. Viable therapeutics for any of these disorders would be a breakthrough and provide relief for the large number of affected patients and their families. Neurodegeneration is accompanied by elevated oxidative damage and inflammation. While natural antioxidants have largely failed in clinical trials, preclinical phenotyping of the unnatural, mitochondrial targeted nitroxide, XJB-5-131, bodes well for further translational development in advanced animal models or in humans. Here we consider the usefulness of synthetic antioxidants for the treatment of Huntington’s disease. The mitochondrial targeting properties of XJB-5-131 have great promise. It is both an electron scavenger and an antioxidant, reducing both somatic expansion and toxicity simultaneously through the same redox mechanism. By quenching reactive oxygen species, XJB-5-131 breaks the cycle between the rise in oxidative damage during disease progression and the somatic growth of the CAG repeat which depends on oxidation.

Research Organization:
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
Sponsoring Organization:
National Institutes of Health; USDOE Office of Science (SC)
Grant/Contract Number:
AC02-05CH11231
OSTI ID:
1892178
Journal Information:
Journal of Huntington's Disease, Journal Name: Journal of Huntington's Disease Journal Issue: 1 Vol. 11; ISSN 1879-6397
Publisher:
IOS PressCopyright Statement
Country of Publication:
United States
Language:
English

References (98)

Heterogeneity of Coenzyme Q10Deficiency journal August 2012
A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease: No Evidence of Benefit journal May 2014
The Mismatch Repair Protein MSH2 is Rate Limiting for Repeat Expansion in a Fragile X Premutation Mouse Model journal November 2013
Mitochondrial-derived reactive oxygen species (ROS) play a causal role in aging-related intervertebral disc degeneration: INTERVETEBRAL DISC OXIDATIVE DAMAGE journal February 2013
Targeting Expanded Repeats by Small Molecules in Repeat Expansion Disorders journal December 2020
Management of oxidative stress and other pathologies in Alzheimer’s disease journal August 2019
Reactive Oxygen Species: Beyond Their Reactive Behavior journal January 2021
A Novel Pharmacological Protective Role for Safranal in an Animal Model of Huntington’s Disease journal February 2021
Antioxidant Combo Therapy Protects White Matter After Traumatic Brain Injury journal January 2021
Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington's disease transgenic mouse model journal November 2001
Effects of coenzyme Q10 administration on its tissue concentrations, mitochondrial oxidant generation, and oxidative stress in the rat journal September 2002
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study journal September 2017
Oral Coenzyme Q10 Supplementation in Patients with Nonalcoholic Fatty Liver Disease: Effects on Serum Vaspin, Chemerin, Pentraxin 3, Insulin Resistance and Oxidative Stress journal October 2014
Conditional ablation of reactive astrocytes to dissect their roles in spinal cord injury and repair journal August 2019
Hemigramicidin–TEMPO conjugates: Novel mitochondria-targeted anti-oxidants journal September 2007
Identification of Genetic Factors that Modify Clinical Onset of Huntington’s Disease journal July 2015
CAG Repeat Not Polyglutamine Length Determines Timing of Huntington’s Disease Onset journal August 2019
Targeting of XJB-5-131 to Mitochondria Suppresses Oxidative DNA Damage and Motor Decline in a Mouse Model of Huntington’s Disease journal November 2012
Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1α in Huntington's disease neurodegeneration journal November 2006
Metabolic Reprogramming in Astrocytes Distinguishes Region-Specific Neuronal Susceptibility in Huntington Mice journal June 2019
Secondary coenzyme Q deficiency in neurological disorders journal March 2021
Evaluation of cytotoxicity of oils used in coenzyme Q10 Self-Emulsifying Drug Delivery Systems (SEDDS) journal April 2004
The chicken or the egg: mitochondrial dysfunction as a cause or consequence of toxicity in Huntington’s disease journal January 2017
Coenzyme Q10 supplementation – In ageing and disease journal July 2021
Evidence for behavioral benefits of early dietary supplementation with CoEnzymeQ10 in a slowly progressing mouse model of Huntington's disease journal February 2012
Small molecules as therapeutic drugs for Alzheimer's disease journal April 2019
Coenzyme Q, oxidative stress and aging journal June 2007
Intergenerational and striatal CAG repeat instability in Huntington's disease knock-in mice involve different DNA repair genes journal January 2009
Advancing the health of our aging population: A lead role for nursing science journal July 2011
Regulation of hepatic coenzyme Q biosynthesis by dietary omega-3 polyunsaturated fatty acids journal October 2021
Protective Effect of Natural Products against Huntington’s Disease: An Overview of Scientific Evidence and Understanding Their Mechanism of Action journal January 2021
Targeting Mitochondria journal January 2008
Superoxide Dismutases and Superoxide Reductases journal January 2014
Mitochondrial Targeting of Selective Electron Scavengers:  Synthesis and Biological Analysis of Hemigramicidin−TEMPO Conjugates journal September 2005
Characterization of Hydantoin Products from One-Electron Oxidation of 8-Oxo-7,8-dihydroguanosine in a Nucleoside Model journal July 2001
Pivotal Role for Two Electron Reduction in 2,3-Dimethoxy-1,4-naphthoquinone and 2-Methyl-1,4-naphthoquinone Metabolism and Kinetics in Vivo That Prevents Liver Redox Stress journal April 2009
Msh2 deficiency prevents in vivo somatic instability of the CAG repeat in Huntington disease transgenic mice journal December 1999
MutSβ promotes trinucleotide repeat expansion by recruiting DNA polymerase β to nascent (CAG)n or (CTG)n hairpins for error-prone DNA synthesis journal June 2016
Double setback for ASO trials in Huntington disease journal May 2021
Failure of genetic therapies for Huntington’s devastates community journal May 2021
OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells journal April 2007
Crosstalk between MSH2–MSH3 and polβ promotes trinucleotide repeat expansion during base excision repair journal August 2016
Lipidomics identifies cardiolipin oxidation as a mitochondrial target for redox therapy of brain injury journal August 2012
(CAG)n-hairpin DNA binds to Msh2–Msh3 and changes properties of mismatch recognition journal July 2005
XJB-5-131 inhibited ferroptosis in tubular epithelial cells after ischemia−reperfusion injury journal August 2020
Prevalence of Parkinson’s disease across North America journal July 2018
Plasma coenzyme Q10 status is impaired in selected genetic conditions journal January 2019
Extrahelical (CAG)/(CTG) triplet repeat elements support proliferating cell nuclear antigen loading and MutL  endonuclease activation journal July 2013
Human MutLγ, the MLH1–MLH3 heterodimer, is an endonuclease that promotes DNA expansion journal February 2020
Coordination between Polymerase β and FEN1 Can Modulate CAG Repeat Expansion journal August 2009
Emerging therapeutics in Huntington’s disease journal July 2021
Coenzyme Q10 and the exclusive club of diseases that show a limited response to treatment journal May 2021
CTG repeat instability and size variation timing in DNA repair-deficient mice journal May 2003
Neurological abnormalities in a knock-in mouse model of Huntington's disease journal January 2001
Somatic expansion behaviour of the (CTG)n repeat in myotonic dystrophy knock-in mice is differentially affected by Msh3 and Msh6 mismatch-repair proteins journal January 2002
Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice journal March 2000
Mitochondrial targeting of XJB-5-131 attenuates or improves pathophysiology in HdhQ150 animals with well-developed disease phenotypes journal February 2016
A modifier of Huntington's disease onset at the MLH1 locus journal July 2017
Somatic CAG expansion in Huntington's disease is dependent on the MLH3 endonuclease domain, which can be excluded via splice redirection journal March 2021
Perfluorooctane Sulfonate (PFOS) Produces Dopaminergic Neuropathology in Caenorhabditis elegans journal August 2019
Mitochondria‐targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants journal August 2003
Mitochondria‐targeted antioxidants journal August 2015
Treatment With a Novel Hemigramicidin-TEMPO Conjugate Prolongs Survival in a Rat Model of Lethal Hemorrhagic Shock journal January 2007
Coenzyme Q10 supplementation: Efficacy, safety, and formulation challenges journal February 2020
Huntington's disease: a clinical review journal September 2017
Bioenergetic analysis of isolated cerebrocortical nerve terminals on a microgram scale: spare respiratory capacity and stochastic mitochondrial failure journal May 2009
Combination therapy with Coenzyme Q10and creatine produces additive neuroprotective effects in models of Parkinson’s and Huntington’s Diseases journal June 2009
Mitochondrial-Targeted Antioxidants Attenuate TGF-β2 Signaling in Human Trabecular Meshwork Cells journal August 2019
A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease journal January 2007
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease journal December 2016
A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington’s disease journal August 2001
Effects of Anthocyanins on CAG Repeat Instability and Behaviour in Huntington’s Disease R6/1 Mice journal January 2016
Deletion of the Huntingtin Polyglutamine Stretch Enhances Neuronal Autophagy and Longevity in Mice journal February 2010
MSH3 Polymorphisms and Protein Levels Affect CAG Repeat Instability in Huntington's Disease Mice journal February 2013
Mismatch Repair Genes Mlh1 and Mlh3 Modify CAG Instability in Huntington's Disease Mice: Genome-Wide and Candidate Approaches journal October 2013
Heterozygosity for a Hypomorphic Polβ Mutation Reduces the Expansion Frequency in a Mouse Model of the Fragile X-Related Disorders journal April 2015
Suppression of Somatic Expansion Delays the Onset of Pathophysiology in a Mouse Model of Huntington’s Disease journal August 2015
Comprehensive Behavioral Testing in the R6/2 Mouse Model of Huntington's Disease Shows No Benefit from CoQ10 or Minocycline journal March 2010
Pms2 Suppresses Large Expansions of the (GAA·TTC)n Sequence in Neuronal Tissues journal October 2012
MutLα Heterodimers Modify the Molecular Phenotype of Friedreich Ataxia journal June 2014
HdhQ111 Mice Exhibit Tissue Specific Metabolite Profiles that Include Striatal Lipid Accumulation journal August 2015
XJB-5-131-mediated improvement in physiology and behaviour of the R6/2 mouse model of Huntington's disease is age- and sex- dependent journal April 2018
GS-Nitroxide (JP4-039)-Mediated Radioprotection of Human Fanconi Anemia Cell Lines journal November 2011
Targeting Mitochondrial Dysfunction and Neurodegeneration by Means of Coenzyme Q10 and its Analogues journal September 2011
Do Naturally Occurring Antioxidants Protect Against Neurodegeneration of the Dopaminergic System? A Systematic Revision in Animal Models of Parkinson's Disease journal February 2022
DNA Mismatch Repair and its Role in Huntington’s Disease journal February 2021
The Use of Coenzyme Q10 in Cardiovascular Diseases journal May 2021
CoQ10 and Aging journal May 2019
Flavonoids: Potential Candidates for the Treatment of Neurodegenerative Disorders journal January 2021
Intracellular Sources of ROS/H2O2 in Health and Neurodegeneration: Spotlight on Endoplasmic Reticulum journal January 2021
Disorders of Human Coenzyme Q10 Metabolism: An Overview journal September 2020
Melatonin and Autophagy in Aging-Related Neurodegenerative Diseases journal September 2020
Cellular Consequences of Coenzyme Q10 Deficiency in Neurodegeneration of the Retina and Brain journal December 2020
CoQ10 Deficient Endothelial Cell Culture Model for the Investigation of CoQ10 Blood–Brain Barrier Transport journal October 2020
Silymarin in Combination with Vitamin C, Vitamin E, Coenzyme Q10 and Selenomethionine to Improve Liver Enzymes and Blood Lipid Profile in NAFLD Patients journal October 2020
Prolonged Intake of Coenzyme Q10 Impairs Cognitive Functions in Mice journal August 2009
Aducanumab: The first targeted Alzheimer's therapy journal June 2021
Enrichment of coenzyme Q10 in plasma and blood cells: defense against oxidative damage journal January 2007